A Study Evaluating the Safety, Pharmacokinetics, and Antiviral Efficacy of SB 9200 in Subjects Infected With Chronic HBV
Clinical trial NCT02751996 · COMPLETED
Trial details
- NCT number
- NCT02751996
- Sponsor
- F-star Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2020-02-10
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.